Establishments
DISTRIBUTOR RENEWAL INFORMATION 2021
ALL DISTRIBUTOR PERMITS WILL EXPIRE 05/31/2021
Your Distributor Permit will expire on May 31, 2021. To renew your distributor permit online, visit the online renewal site at: https://mdbop.mylicense.com/eGov/PersonSearchResults.aspx?Facility=Y
The renewal period begins on March 15, 2021.
All Distributors including Wholesale Distributors, Manufacturers and Virtual Manufacturers Distributing Their Own Prescription Drugs or Devices may renew online. Only Visa or MasterCard are accepted as forms of payment for the online renewal.
You may also renew by downloading and submitting a paper renewal application along with a check or money order.
A completed application postmarked or received by the Board on or before May 31, 2021, must be accompanied by a $1,750.00 renewal fee. Applications postmarked after May 31, 2021, are subject to a $3,250.00 fee ($1,750 renewal fee plus $1,500 reinstatement fee).
PLEASE NOTE: You must submit a substantially completed application at least 14 days before May 31, 2021, to guarantee an uninterrupted period of licensure. If you submit your application between May 18 and May 31, 2021, your permit may lapse before processing is complete, and you may be subject to an additional reinstatement fee.
For more information and instructions on the online renewal process, please contact the Board via email: mdh.mdbop@maryland.gov.
The completed renewal application may be mailed, along with a check or money order, to:
Maryland Board of Pharmacy, P.O. Box 2024, Baltimore, MD 21203-2024
Applications sent overnight or through priority mail must be addressed to:
Wells Fargo Bank, Attn: State of MD – Board of Pharmacy, Lockbox 2024
7175 Columbia Gateway Drive, Columbia, MD 21046
Wholesale Distributors can now renew online by clicking here.
View tutorials on the online renewal process by clicking here.
Background Check Information: Click Here
The Maryland Board of Pharmacy requires Accreditation for companies residing in states that do not have requirements that are 'substantially equivalent to Maryland’s wholesale distributor requirements.'
Distributors may obtain NCDQS QAS Accreditation.
National Coalition for Drug Quality & Security 8 The Green, Suite A, Dover, DE 19901 info@ncdqs.org Denise M. Frank, RPh
Director of Accreditation and Inspection Services
612-860-1705
All applications and correspondence related to the processing of applications and related documents for the Maryland Board of Pharmacy shall be sent to the following mailing addresses:
Pharmacies, Distributors, Manufacturers (new, renewal, and reinstatement), Non-Resident Pharmacy (new, renewal, reinstatement), Pharmacy Waiver (new, renewal, and reinstatement), and any related correspondence:
Maryland Board of Pharmacy
P O Box 2024
Baltimore, MD 21203-2024
Applications sent overnight or by priority mail should be addressed to the appropriate lockbox and sent to:
Wells Fargo Bank
Attn: State of MD – Board of Pharmacy
Lockbox 2024
401 Market Street
Philadelphia, PA 19106
NOTE: Applications and forms shall be completed in their entirety and the appropriate payment attached and sent to the appropriate P.O. Box. Payments in the form of cash or money order will not be accepted at the Board of Pharmacy on a walk-in basis; however, the Board will accept credit card payments. Please make sure to download the current application from the Board’s website. The Board of Pharmacy will no longer accept outdated applications. If you submit an outdated application, it will be returned and will delay the processing of your application. All documents and correspondence related to Compliance, Investigations, and Inspections will be sent directly to the Board of Pharmacy at 4201 Patterson Avenue, Baltimore, MD 21215-2299.
Additional Links
Sterile Compounding Adverse Event Reporting
Theft or Loss of Controlled Substances Report
For more information about the new DME/Device Only Pharmacy Law Change
Click HERE
Inspection Forms
Important Sterile Compounding Information
The Sterile Compounding Permit Program was repealed during the 2015 Legislative Session by the passage of SB 69/HB 181 entitled “State Board of Pharmacy – Sterile Compounding – Compliance by Nonresident Pharmacies and Repeal of Permit Requirement,” effective April 14, 2015. Therefore, there is no separate permit required for a pharmacy performing sterile compounding pursuant to a patient specific prescription.
Click HERE for more information